ND-003 (NewDEL Biotech)

N/A

Report date: 2025/04/17 10:23:56
NME

Base Information

Drug NameND-003 (NewDEL Biotech)
Drug Alias NameND003 (NewDEL Biotech)ND-003 (NewDEL Biotech)ND003JND-5932
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor RET inhibitorsTropomyosin-related kinase inhibitorsStem cell growth factor receptor inhibitors +[5] 
TargetsTyrosine-protein kinase receptor RETTropomyosin-related kinaseStem cell growth factor receptor +[5] 
Therapy Area/IndicationsRenal fibrosisSolid tumoursDermatitis, Atopic +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShenzhen NewDEL Biotech Co LtdJinan University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen NewDEL Biotech Co LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co Ltd
Inactive CompaniesN/A
Active IndicationsRenal fibrosisSolid tumoursDermatitis, Atopic +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A